GLOBAL BLOOD THERAPEUTICS, INC. stock price today and history
GLOBAL BLOOD THERAPEUTICS, INC. (GBT) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
GLOBAL BLOOD THERAPEUTICS, INC. stock price
GLOBAL BLOOD THERAPEUTICS, INC. latest news:
BRIEF-Global Blood Therapeutics posts Q3 loss per share $0.66
* Global Blood Therapeutics reports recent business
provides third quarter 2017 financial results
Global Blood Therapeutics stock declines after forsaking half its drug pipeline
The pressure is on for GBT440 to succeed in sickle cell disease, which could bring in billions of dollars in revenue. Biotech Global Blood Therapeutics Inc. shares declined in Monday trade after the company announced that it is axing research that amounts to half of its drug development pipeline. Global Blood Therapeutics (GBT) had been studying its main, and only, drug GBT440 in two conditions, idiopathic pulmonary fibrosis and sickle cell disease, which affect the body in different...
BRIEF-Point72 Asset Management LP reports 5.2 pct passive stake in Global Blood Therapeutics
* Point72 Asset Management LP reports 5.2 percent passive
stake in Global Blood Therapeutics Inc as of October 2 - SEC
Source text: (http://bit.ly/2yH9e9Y)
Further company coverage: